CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Guidelines

2004

Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents - MMWR 2004; 53 (RR15)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm

PDF

Treating Opportunistic Infections Among HIV-Exposed and Infected Children - MMWR 2004; 53 (RR14)
www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm

PDF
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor - Alpha - California, 2002–2003 - MMWR 2004; 53 (No. 30)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5330a4.htm
PDF
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2004; 53 (No. 2)
www.cdc.gov/mmwr/preview/mmwrhtml/mm5302a6.htm
PDF

Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
www.cdc.gov/nchstp/tb/TB_HIV_Drugs/TOC.htm

PDF

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333